Latest filing published 13 Sept 2013 for Trius Therapeutics Inc.
No signal scores available.
This profile gathers the share dealings of John Finn in Trius Therapeutics Inc. We count 34 filings; the first trade dates from 17 February 2011 and the latest from 11 September 2013.
Sales make up the whole of the open-market record (31 sales, €291k). Besides market trades, the filings include 1 option exercise. So far in 2013, the count stands at no purchases and 12 sales.
The latest filing, published on 13 September 2013, reports a transaction in Trius Therapeutics Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 33 declarations